Prostate Cancer Education Forum

Patient Newsletter 2024 September

Patient Newsletter 2024 August

HOA is the First Cancer Care Center in New York State to Offer Bispecific Antibody Therapy in an Outpatient Setting - Eliminating the Need for a Mandatory Hospital Stay

Hematology-Oncology Associates of CNY (HOA) has successfully treated a patient with bispecific antibody therapy for small-cell lung cancer as an outpatient. Reports show that while this therapy has been successfully administered in the outpatient setting in other parts of the United States, this is the first time it has been provided for someone outside of the hospital in New York State.

CNY cancer practice plans to ramp up cutting-edge therapy after successful outpatient treatment

Gail Mauro (center) receives her final step-up dose of bispecific antibody therapy at Hematology-Oncology Associates of CNY. She is pictured here with her husband, Joe (right) along with HOA Physician Assistant and Clinical Manager Denise Lougee. Joe serves as Gail’s at-home caregiver, which is a requirement of this new program.

Courtesy of HOA

 

By 

Lung Cancer Information

Patient Newsletter 2024 July

Sarcoma Education Sheet

Melanoma, 20210031

The purpose of this study is to assess the efficacy, safety, and immunogenicity of ABP 206 compared with Nivolumab in Subjects with Treatment-Naïve Unresectable or Metastatic Melanoma.

Lung, IMM1104-101

A phase 1/2a open label study of IMM-1-104 in Participants with Un-resectable or Metastatic Previously Treated Pancreatic Cancer or RAS Mutated NSCLC or Melanoma

Pages